Emily is a Monash-Warwick Alliance joint appointment PhD student supervised by Dr Pu Chun Ke (Monash University), Dr Paul Wilson (University of Warwick), and Professor Tom Davis (Monash University), and is a co-leader for the CBNS Signature Project ‘Mediating protein interactions’. She moved to Australia from New Zealand in 2011 and completed her Bachelor of Science with Honours (First Class) at Monash University in 2014, majoring in Microbiology and Genetics with a minor in Pharmacology, and spent a year working as a Research Assistant at the Monash Institute of Pharmaceutical Science before commencing her PhD. A biologist by training, her key research interests concern amyloid aggregation in the context of type 2 diabetes and the protein corona.
Click here for a profile video of Emily.
|Pancreatic β-Cell Membrane Fluidity and Toxicity Induced by Human Islet Amyloid Polypeptide Species||2016||Pilkington, E.H.; Gurzov, E.N.; Kakinen, A.; Litwak, S.A.; Stanley, W.J.; Davis, T.P.; Ke, P.C|
|Star Polymers Reduce IAPP Toxicity via Accelerated Amyloid Aggregation||2017||Emily H. Pilkington, May Lai, Xinwei Ge, William J Stanley, Bo Wang, Miaoyi Wang, Aleksandr Kakinen, Marc-Antoine Sani, Michael R. Whittaker, Esteban N Gurzov, Feng Ding, John F. Quinn, Thomas P. Davis, and Pu Chun Ke|
|Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer||2016||Esteban N. Gurzov, Bo Wang, Emily H. Pilkington, Pengyu Chen, Aleksandr Kakinen, William J. Stanley, Sara A. Litwak, Eric G. Hanssen, Thomas P. Davis, Feng Ding, Pu Chun Ke|
|Lysophosphatidylcholine modulates the aggregation of human islet amyloid polypeptide||2017||Yanting Xing, Emily H. Pilkington, Miaoyi Wang, Cameron J. Nowell, Aleksandr Kakinen, Yunxiang Sun, Bo Wang, Thomas P. Davis, Feng Ding, Pu Chun Ke|
|Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity||2017||Pilkington E.H., Xing Y, Wang B, Kakinen A, Wang M, Davis TP, Ding F, Ke PC|